Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|October 1, 1993
Autologous bone marrow transplantation for acute lymphoblastic leukemiaK Doney, C D Buckner, L Fisher, et al.
Bone Marrow Transplantation|January 1, 1989
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantationR S Hill, P Mazza, D Amos, et al.
The New England Journal of Medicine|January 26, 1989
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphomaC Anasetti, D Amos, P G Beatty, et al.
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
Bone Marrow Transplantation|February 22, 2005
Outcome of unrelated transplants in patients with multiple myelomaK K Ballen, R King, M Carston, et al.
Bone Marrow Transplantation|March 2, 1997
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemiaD Seong, S Giralt, H Fischer, et al.
Journal of Clinical Apheresis|December 18, 2001
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresisM Körbling, S Giralt, I Khouri, et al.
Bone Marrow Transplantation|January 1, 1993
Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantationC Ippoliti, D Przepiorka, S Giralt, et al.
Blood|June 1, 1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cellsM Talpaz, H Kantarjian, J Liang, et al.
Leukemia & Lymphoma|May 1, 1995
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphomaD Przepiorka, R Nath, C Ippoliti, et al.
Pageof 21